Wall Street Analysts See a 26.01% Upside in Agios Pharmaceuticals (AGIO): Can the Stock Really Move This High?

Group 1 - Agios Pharmaceuticals (AGIO) closed at $32.80, with a 10.4% gain over the past four weeks, and a mean price target of $41.33 indicating a 26% upside potential [1] - The mean estimate includes six short-term price targets with a standard deviation of $8.12, suggesting variability in analyst predictions; the lowest estimate is $30 (8.5% decline), while the highest is $49 (49.4% increase) [1] - Analysts show a strong agreement in revising earnings estimates higher, with the Zacks Consensus Estimate increasing by 8.8% over the last 30 days, indicating positive sentiment towards AGIO's earnings prospects [6] Group 2 - The consensus price target is often questioned for its reliability, as analysts may set overly optimistic targets influenced by business relationships [3][5] - A low standard deviation in price targets indicates a high degree of agreement among analysts regarding the stock's price movement direction [4] - AGIO holds a Zacks Rank 2 (Buy), placing it in the top 20% of over 4,000 ranked stocks based on earnings estimates, suggesting a solid potential upside [6]